Cell Applications, Inc. Launches Human Dendritic Cells and Media SAN DIEGO, Aug 26, 2016 — Today CAI introduced Human Dendritic Cells to their primary Blood Cell portfolio. Isolated from peripheral blood, the cells (HDC-PB for short) arise from a distinct hematopoietic lineage and help regulate the immune system. They mount adaptive immune responses to foreign antigens, […]
Human Blood and Cardiovascular Portfolio Expands at CAI SAN DIEGO, May 16, 2016 — Officials at Cell Applications, Inc. announce the addition of primary cells to their collection of Blood and Cardiac cells. Human Peripheral Blood Mononuclear Cells, or “PBMC” for short, provide a useful in vitro research tool for various aspects of pathology and biology. PBMC […]
Human Blood and Cardiovascular Portfolio Expands at CAI SAN DIEGO, May 16, 2016 — Officials at Cell Applications, Inc. announce the addition of primary cells to their collection of Blood and Cardiac cells. Human Peripheral Blood Mononuclear Cells, or “PBMC” for short, provide a useful in vitro research tool for various aspects of pathology and biology. PBMC […]
CAI Launches Serum- & Xeno-Free versions of its Human Mesenchymal Stem Cell Media SAN DIEGO, July 14, 2015 — To further optimize culture of Human Mesenchymal Stem Cells, Cell Applications, Inc. introduces Serum- and Xeno-Free versions to its line of HMSC Media. The optimized formulations reduce variation, increase reproducibility and facilitate expansion. For particular applications, HMSC […]